Conteduca, V. http://orcid.org/0000-0002-6921-714X
Medri, M.
Mazzoni, L.
De Giorgi, U.
Stanganelli, I.
Article History
Received: 21 May 2021
Accepted: 18 October 2021
First Online: 27 October 2021
Declarations
:
: V. Conteduca received speaker honoraria or travel support from Astellas, Janssen-Cilag, and Sanofi-Aventis. V. Conteduca received consulting fee from Bayer and is an advisory board member of Janssen, Astellas, AstraZeneca, and Merck. U. De Giorgi reports grants from AstraZeneca; personal fees from Astellas, Bayer, Novartis, Merck Sharp & Dohme, and Pharmamar; grants and personal fees from Sanofi; grants and non-financial support from Roche; and personal fees and non-financial support from Janssen-Cilag, Pfizer, Bristol Myers Squibb, and Ipsen. No potential conflicts of interest were disclosed by the other authors.